跳至主要内容
临床试验/NCT05861570
NCT05861570招募中不适用

Steroid and Sodium Hyaluronate Hydrodilatation

Taipei Veterans General Hospital, Taiwan1 个研究点 分布在 1 个国家目标入组 84 人开始时间: 2023年5月18日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
84
试验地点
1
主要终点
change in pain intensity

研究概览

简要总结

This study was conducted to compare the efficacy of hydrodilatation with steroid with hyaluronic acid and steroid for treating adhesive capsulitis.

详细描述

Design: a prospective, double-blinded, randomized, clinical trial

Patient and methods:

Patients with adhesive capsulitis for at least 3 months were enrolled and randomly allocated into group 1 (hydrodilatation with steroid ) and group 2 (hydrodilatation with hyaluronic acid and steroid). The patients were evaluated before treatment and were reevaluated 0, 6, and 12 weeks after the beginning of the treatment. Outcomes measures included a pain scale (visual analog scale), range of motion, Shoulder Pain And Disability Index

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

盲法说明

Double (Participant, Outcomes Assessor)

入排标准

年龄范围
35 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age 35-65 years
  • onset of shoulder stiffness since over a month
  • limitation in the passive range of motion (ROM) over 30° when compared with the contralateral side in at least two of these three movements: forward flexion, abduction, or external rotation.

排除标准

  • ultrasound findings of rotator cuff tears,
  • plain radiography findings of significant glenohumeral joint arthritis,
  • accompanying cervical radiculopathy,
  • systemic inflammatory joint disease,
  • intraarticular injection into the glenohumeral joint within the past 3 months
  • history of surgery on the affected shoulders,
  • regular use of systemic non-steroidal anti-inflammatory drugs or corticosteroids,
  • allergy to corticosteroid or lidocaine.

研究组 & 干预措施

hydrodilatation with steroid

Experimental

patient received ultrasound-guided 3cc NS + 40mg triamcinolone + 4cc xylocaine

干预措施: normal saline (Drug)

hydrodilatation with steroid

Experimental

patient received ultrasound-guided 3cc NS + 40mg triamcinolone + 4cc xylocaine

干预措施: lidocaine hydrochloride (Drug)

hydrodilatation with steroid

Experimental

patient received ultrasound-guided 3cc NS + 40mg triamcinolone + 4cc xylocaine

干预措施: Triamcinolone Acetonide (Drug)

hydrodilatation with hyaluronic acid and steroid

Active Comparator

patient received ultrasound-guided 3cc hyaluronic acid + 40mg triamcinolone + 4cc xylocaine

干预措施: (Sodium Hyaluronate (Hyruan One , LG) (Drug)

hydrodilatation with hyaluronic acid and steroid

Active Comparator

patient received ultrasound-guided 3cc hyaluronic acid + 40mg triamcinolone + 4cc xylocaine

干预措施: lidocaine hydrochloride (Drug)

hydrodilatation with hyaluronic acid and steroid

Active Comparator

patient received ultrasound-guided 3cc hyaluronic acid + 40mg triamcinolone + 4cc xylocaine

干预措施: Triamcinolone Acetonide (Drug)

结局指标

主要结局

change in pain intensity

时间窗: 0, 6, 12weeks

pain intensity was measured by visual analog scale (0-10)

次要结局

  • change in glenohumeral joint range of motion(0, 6, 12weeks)
  • change in Shoulder Pain And disability index(0, 6, 12 weeks)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验